TITLE

Lucina

PUB. DATE
September 2007
SOURCE
Archives of Disease in Childhood;Sep2007, Vol. 92 Issue 9, p830
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers world news briefs related to pediatrics. A routine infant vaccination with seven-valent pneumococcal conjugate vaccine has been introduced in the U.S. The implementation of neonatal screening for cystic fibrosis was found to be cost-saving in Great Britain. A child with inherited deficiency of glycosylphosphatidylinositol (GPI) has been treated through sodium phenylbutyrate.
ACCESSION #
26522980

 

Related Articles

  • Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) In Older Adults. Sanford, Mark // Drugs;2012, Vol. 72 Issue 9, p1243 

    Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [PCV13] is approved for protection against pneumococcal disease in children aged 6 weeks to 5 years and adults aged ≥50 years. In randomized trials in adults aged 60-64 years (not previously vaccinated with 23-valent...

  • Genotypic and phenotypic characterisation of invasive Streptococcus pneumoniae isolates from Hungary, and coverage of the conjugate vaccines. Orsolya Dobay // Journal of Clinical Pathology;Dec2010, Vol. 63 Issue 12, p1116 

    BACKGROUND AND AIMS: The 7-valent conjugate pneumococcal vaccine (Prevenar) was introduced as a recommended (but not yet obligatory) vaccine in Hungary in April 2009 and there was a sharp increase in the number of children vaccinated. Hence there is an urgent need for in-depth epidemiological...

  • Rethinking Recommendations for Use of Pneumococcal Vaccines in Adults. Whitney, Cynthia G.; Schaffner, William; Butler, Jay C. // Clinical Infectious Diseases;9/1/2001, Vol. 33 Issue 5, p1 

    Streptococcus pneumoniae remains a major cause of disease worldwide; the emergence of antibiotic-resistant strains emphasizes the importance of disease prevention by use of vaccines. Recent studies have provided information that is useful for the evaluation of current vaccine recommendations....

  • Pneumococcal Conjugate Vaccine for Young Children. Zimmerman, Richard Kent // American Family Physician;5/15/2001, Vol. 63 Issue 10, p1991 

    Streptococcus pneumoniae causes approximately 3,300 cases of meningitis, 100,000 to 135,000 cases of pneumonia requiring hospitalization and 6 million cases of otitis media annually in the United States. Pneumococcal conjugate vaccine, approved in 2000 for use in the United States, was designed...

  • Splenectomy for Hematological Disorder: in Iranian Pediatric Patients: A Single Center Study. Shahin Shamsian, Bibi; Thaghi Arzanian, Mohammad; Kaviani, Raheleh; Alavi, Samin; Hedayat, Mona; Rezaei, Nima // Iranian Journal of Pediatrics;Jun2012, Vol. 22 Issue 2, p275 

    A letter to the editor is presented wherein the authors discuss a study addressing issues related to the enforcement of and compliance with current prevention guidelines among splenectomized patients in a tertiary care setting in the June 2012 issue of the journal.

  • Pneumococcal vaccination: time to move on? Proesmans, Marijke Johanna // European Journal of Pediatrics;Nov2010, Vol. 169 Issue 11, p1435 

    The author comments on a study focusing on the surveillance of pediatric invasive pneumococcal infections in a tertiary care pediatric center in Quebec after the government-sponsored introduction of pneumococcal conjugate vaccine-7 (PCV-7) for children up to age 5 in a 2+1 schedule for infants....

  • Pneumococcal-vaccine: Flare up of Mevalonate kinase deficiency: case report.  // Reactions Weekly;6/29/2019, Vol. 1759 Issue 1, p212 

    No abstract available.

  • Pneumococcal disease in India: The dilemma continues. Mathew, Joseph L.; Singhi, Sunit // Indian Journal of Medical Research;Aug2014, Vol. 140 Issue 2, p165 

    The author discusses a research study by Ravi Kumar and colleagues on the prevalence of pneumococcal infection in infants and children in India. Topics discussed include the antimicrobial resistance pattern of isolated Streptococcus pneumoniae, effectiveness of vaccine serotypes in eliminating...

  • Paediatric airway infections.  // Thorax;Dec2013 Supplement, Vol. 68 Issue S3, pA39 

    The article presents abstracts on paediatric airway infections research topics which include effect of pneumococcal vaccine introduction on variants of pneumococcal empyema, bronchoscopy need for bacterial bronchitis child patients, and clinical severity score for infant bronchiolitis patients.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics